Strategic acquisition in Orange County establishes a major West Coast pharmaceutical infrastructure investment, with advanced sterile and hazardous drug compounding capabilities.
ORANGE COUNTY, CALIFORNIA — [November 19, 2026] — The Wellness Group (TWG), a rapidly expanding, vertically integrated American healthcare and wellness infrastructure company, today announced the acquisition of a 12,000-square-foot specialized biotechnology and pharmaceutical facility in Orange County, California.

Located in Orange, California, the facility represents another significant milestone in TWG’s previously announced $250 million investment strategy to build the next generation of healthcare and pharmaceutical infrastructure across the United States.
The acquisition significantly expands TWG’s physical presence on the West Coast and provides a strategic foundation for the development of a state-of-the-art pharmaceutical compounding operation.
Foster Coulson, Founder and Chief Executive Officer of The Wellness Group, emphasized the strategic importance of establishing a world-class pharmaceutical facility in California.
“California is one of the most important healthcare markets in the country, and we believe having a world-class pharmaceutical facility in the state is essential to our long-term strategy. We’re making substantial investments in California because we see an extraordinary opportunity to improve how pharmaceutical products are developed, prepared, and delivered to patients.”
“Our philosophy is simple: if we’re going to participate in healthcare, we’re going to invest in the infrastructure necessary to do it exceptionally well. That means world-class facilities, advanced technology, exceptional people, and an uncompromising commitment to quality. This acquisition represents another important step in building that foundation.”
— Foster Coulson, Founder & CEO, The Wellness Group
The Orange County facility will become an important component of TWG’s expanding national pharmaceutical infrastructure strategy, complementing the company’s investments in Florida and other U.S. markets.
Tom Rebhandl, Chief Executive Officer of TWG’s Pharmacy Division, Scriptful RX, highlighted the company’s focus on technology, product quality, and operational excellence.
“Our vision is to build one of the most advanced pharmacy networks in the country, and California is a critical part of that strategy. This facility gives us an exceptional foundation to develop highly specialized sterile and hazardous compounding capabilities, supported by modern technology, sophisticated quality systems, and pharmaceutical expertise.”
— Tom Rebhandl, CEO, Pharmacy Division, ScriptfulRX, The Wellness Group
The acquisition represents another step in The Wellness Group’s aggressive expansion throughout the American healthcare and pharmaceutical industries.
Through strategic acquisitions, facility development, technology investments, and operational integration, TWG is acquiring a national infrastructure platform designed to support the evolving needs of healthcare providers and consumers.
About The Wellness Group
The Wellness Group (TWG) is a vertically integrated healthcare and wellness infrastructure company focused on transforming how healthcare products and services are developed, prescribed, manufactured, and delivered across the United States.
Through its expanding portfolio of businesses, TWG operates across telemedicine, pharmaceutical fulfillment, sterile and non-sterile compounding, healthcare technology, patient care management, and consumer wellness products.
With a commitment to investing up to $250 million in U.S. healthcare infrastructure, TWG is building an integrated national platform designed to support healthcare providers, consumer brands, and patients through innovation, operational excellence, and uncompromising quality.
For more information, visit www.TWG.Health.